Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glymphatic Clearance During Anesthesia and Sleep
NCT02768688Phase 1Completed
- Sponsor
- University of Pennsylvania
- Start
- Jul 2014
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of dexmedetomidine, sponsored by University of Pennsylvania. Primary endpoint: Glymphatic clearance from the human brain at 2 hours. Started Jul 2014; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT02768688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02768688.